{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T11:03:03Z","timestamp":1784026983277,"version":"3.55.0"},"reference-count":51,"publisher":"SAGE Publications","issue":"7","license":[{"start":{"date-parts":[[2013,6,29]],"date-time":"2013-06-29T00:00:00Z","timestamp":1372464000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Journal of Women's Health"],"published-print":{"date-parts":[[2016,7]]},"abstract":"<jats:p>Evidence-based guidance regarding use of nearly all pharmaceuticals by pregnant and lactating women is limited. Models for performing research may assist in filling these knowledge gaps. Internationally, reproductive age women are at high risk of human immunodeficiency virus (HIV) acquisition. Susceptibility to HIV infection may be increased during pregnancy, and risk of maternal-child transmission is increased with incident HIV infection during pregnancy and lactation. A multidisciplinary meeting of experts was convened at the United States National Institutes of Health to consider paradigms for drug research in pregnancy and lactation applicable to HIV prevention. This report summarizes the meeting proceedings and describes a framework for research on candidate HIV prevention agent use during pregnancy and lactation that may also have broader applications to other pharmaceutical products.<\/jats:p>","DOI":"10.1089\/jwh.2013.4398","type":"journal-article","created":{"date-parts":[[2013,6,29]],"date-time":"2013-06-29T09:47:56Z","timestamp":1372499276000},"page":"761-766","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":10,"title":["Performing Drug Safety Research During Pregnancy and Lactation: Biomedical HIV Prevention Research as a Template"],"prefix":"10.1177","volume":"25","author":[{"given":"Richard H.","family":"Beigi","sequence":"first","affiliation":[{"name":"Magee-Womens Hospital of the University of Pittsburgh Medical Center"},{"name":"Magee-Womens Research Institute"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Noguchi","sequence":"additional","affiliation":[{"name":"Magee-Womens Research Institute"},{"name":"Johns Hopkins University Bloomberg School of Public Health"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gina","family":"Brown","sequence":"additional","affiliation":[{"name":"National Institutes of Health"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeanna","family":"Piper","sequence":"additional","affiliation":[{"name":"National Institutes of Health"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D. Heather","family":"Watts","sequence":"additional","affiliation":[{"name":"National Institutes of Health"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2013,6,29]]},"reference":[{"key":"e_1_3_3_2_2","doi-asserted-by":"publisher","DOI":"10.1002\/ajmg.c.30313"},{"key":"e_1_3_3_3_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.clpt.6100448"},{"key":"e_1_3_3_4_2","doi-asserted-by":"publisher","DOI":"10.2165\/00002018-200427040-00001"},{"key":"e_1_3_3_5_2","unstructured":"The Second Wave Initiative. http:\/\/secondwaveinitiative.org\/Home.html"},{"key":"e_1_3_3_6_2","doi-asserted-by":"publisher","DOI":"10.1038\/465689a"},{"key":"e_1_3_3_7_2","unstructured":"United States Food and Drug Administration (USFDA). Vaginal microbicides: Development for the prevention of HIV infection. 2012. Available at: www.fda.gov\/Drugs\/GuidanceComplianceRegulatoryInformation\/Guidances\/ucm328834.htm?source=govdelivery Accessed December8 2012."},{"key":"e_1_3_3_8_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMp1003462"},{"key":"e_1_3_3_9_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2010.479"},{"key":"e_1_3_3_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2011.03.002"},{"key":"e_1_3_3_11_2","unstructured":"World Health Organization (WHO). AIDS epidemic update. 2009. Available at: http:\/\/data.unaids.org\/pub\/Report\/2009\/JC1700_Epi_Update_2009_en.pdf Accessed May11 2011."},{"key":"e_1_3_3_12_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1105243"},{"key":"e_1_3_3_13_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.1193748"},{"key":"e_1_3_3_14_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1011205"},{"key":"e_1_3_3_15_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1108524"},{"key":"e_1_3_3_16_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1202614"},{"key":"e_1_3_3_17_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1110711"},{"key":"e_1_3_3_18_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jir562"},{"key":"e_1_3_3_19_2","doi-asserted-by":"publisher","DOI":"10.1089\/jwh.2007.0730"},{"key":"e_1_3_3_20_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.AOG.0000220507.91904.4a"},{"key":"e_1_3_3_21_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.AOG.0000223229.83920.af"},{"key":"e_1_3_3_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(05)67481-8"},{"key":"e_1_3_3_23_2","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0b013e3280f00fc4"},{"key":"e_1_3_3_24_2","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0b013e32834a9338"},{"key":"e_1_3_3_25_2","doi-asserted-by":"publisher","DOI":"10.1097\/AOG.0b013e3181e00955"},{"key":"e_1_3_3_26_2","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0b013e3283489d45"},{"key":"e_1_3_3_27_2","volume-title":"Institute of Medicine (IOM)","author":"Lagakos S","year":"2008","unstructured":"Lagakos S. Methodological challenges in biomedical HIV prevention trials. In: Medicine Io, ed. Institute of Medicine (IOM), Washington, DC: National Academies Press; 2008."},{"key":"e_1_3_3_28_2","unstructured":"WHO. Global Health Observatory Data Repository. Data on the size of the epidemic prevalence of HIV among adults aged 15 to 49 (%). 2009. Available at: http:\/\/apps.who.int\/ghodata"},{"key":"e_1_3_3_29_2","unstructured":"WHO. Infant and young child feeding data by country. 2012. Available at: www.who.int\/nutrition\/databases\/infantfeeding\/countries\/en\/index.html."},{"key":"e_1_3_3_30_2","unstructured":"WHO. Indicators for assessing infant and young child feeding practices\u2014part III: country profiles. WHO 2010. Available at: www.who.int\/maternal_child_adolescent\/documents\/9789241599757\/en\/index.html."},{"key":"e_1_3_3_31_2","doi-asserted-by":"publisher","DOI":"10.1080\/13691051003783339"},{"key":"e_1_3_3_32_2","doi-asserted-by":"publisher","DOI":"10.2105\/AJPH.2006.088682"},{"key":"e_1_3_3_33_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.c6580"},{"key":"e_1_3_3_34_2","doi-asserted-by":"publisher","DOI":"10.1086\/605123"},{"key":"e_1_3_3_35_2","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-200011100-00016"},{"key":"e_1_3_3_36_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199512283332604"},{"key":"e_1_3_3_37_2","first-page":"941","article-title":"The relationship of amniotic fluid cytokines and preterm delivery, amniotic fluid infection, histologic chorioamnionitis, and chorioamnion infection","volume":"81","author":"Hillier SL","year":"1993","unstructured":"Hillier SL, , Witkin SS, , Krohn MA, , Watts DH, , Kiviat NB, , Eschenbach DA. The relationship of amniotic fluid cytokines and preterm delivery, amniotic fluid infection, histologic chorioamnionitis, and chorioamnion infection. Obstet Gynecol, 1993; 81:941\u2013948.","journal-title":"Obstet Gynecol"},{"key":"e_1_3_3_38_2","doi-asserted-by":"publisher","DOI":"10.1067\/S0002-9378(03)00582-9"},{"key":"e_1_3_3_39_2","doi-asserted-by":"publisher","DOI":"10.1097\/00006250-200209000-00012"},{"key":"e_1_3_3_40_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.0050022"},{"key":"e_1_3_3_41_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2004.04.025"},{"key":"e_1_3_3_42_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2005.02.100"},{"key":"e_1_3_3_43_2","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-200544100-00001"},{"key":"e_1_3_3_44_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.clpt.6100136"},{"key":"e_1_3_3_45_2","unstructured":"U.S. Department of Health and Human Services (USDHHS). Code of Federal Regulations Title 45. Public welfare. Part 46. Protection of human subjects. Subpart B. Available at: www.hhs.gov\/ohrp\/humansubjects\/guidance\/45cfr46.html#subpartb"},{"key":"e_1_3_3_46_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(10)60257-7"},{"key":"e_1_3_3_47_2","doi-asserted-by":"publisher","DOI":"10.3138\/ijfab.1.2.5"},{"key":"e_1_3_3_48_2","doi-asserted-by":"publisher","DOI":"10.1080\/15265161.2011.560353"},{"key":"e_1_3_3_49_2","doi-asserted-by":"publisher","DOI":"10.1080\/15265161.2011.562595"},{"key":"e_1_3_3_50_2","unstructured":"Committee APR. The antiretroviral pregnancy registry. 2012. Available at: www.apregistry.com\/who.htm."},{"key":"e_1_3_3_51_2","unstructured":"USDHHS and USFDA. Guidance for industry: Reproductive and developmental toxicities\u2014integrating study results to assess concerns. September 2011. Available at: www.fda.gov\/downloads\/Drugs\/GuidanceComplianceRegulatoryInformation\/Guidances\/UCM079240.pdf"},{"key":"e_1_3_3_52_2","unstructured":"USDHHS. Code of Federal Regulations. Title 45. Public welfare. Part 46. Protection of human subjects. \u00a746.204. Research involving pregnant women or fetuses. Available at: www.hhs.gov\/ohrp\/humansubjects\/guidance\/45cfr46.html#46.204"}],"container-title":["Journal of Women's Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1089\/jwh.2013.4398","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1089\/jwh.2013.4398","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1089\/jwh.2013.4398","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T21:22:17Z","timestamp":1781558537000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1089\/jwh.2013.4398"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,6,29]]},"references-count":51,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2016,7]]}},"alternative-id":["10.1089\/jwh.2013.4398"],"URL":"https:\/\/doi.org\/10.1089\/jwh.2013.4398","relation":{},"ISSN":["1540-9996","1931-843X"],"issn-type":[{"value":"1540-9996","type":"print"},{"value":"1931-843X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,6,29]]}}}